Below are the most recent publications written about "Naloxone" by people in Profiles.
-
Gautam K, Paudel K, Wickersham JA, Khati A, Thapa A, Bhusal S, Sujan MSH, Pagoto S, Ha T, Shrestha R. Smartphone-Based Ecological Momentary Assessment to Monitor Opioid Use and Overdose Among People Who Use Opioids: Prospective Observational Feasibility Study. JMIR Hum Factors. 2026 Jun 29; 13:e95655.
-
Moore PQ, Mixson LS, Bolinski R, Colston DC, Cooper HLF, Crane HM, Devadas J, Feinberg J, Friedmann PD, Gicquelais RE, Jenkins WD, Khoury D, Korthuis PT, Smith G, Stopka TJ, Westergaard R, Young A, Pho MT. Correlates of Rural Naloxone Possession Among People Who Use Drugs: A Multi-State Cross-Sectional Analysis. J Rural Health. 2026 Jun; 42(3):e70187.
-
Chatterjee A, Chase RP, Chahine RA, Davis J, Dsouza N, Ellison S, Bagley SM, Fisher T, Glasgow L, Harris MTH, Huang TT, Holloway J, Lounsbury DW, Oga E, Asman K, Roberts SM, Sabounchi N, Surratt HL, Lines LM, Stadler HW, Taylor JL, Davis A. Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths. J Subst Use Addict Treat. 2026 Jan; 180:209828.
-
Mixson LS, Zule W, Ruderman SA, Feinberg J, Stopka TJ, Sibley AL, Walters SM, Bobashev G, Cook R, Hochstatter KR, Fahey CA, Ouellet LJ, Fredericksen R, Cooper HLF, Young AM, Zibbell J, Khoury D, Friedmann PD, Miller WC, Korthuis PT, Westergaard RP, Whitney BM, Tsui JI, Crane HM, Delaney J. Prevalence and correlates of multiple injections per injection episode among people who inject drugs in rural U.S. communities. Int J Drug Policy. 2025 09; 143:104837.
-
Broach JP, Rettger B, Gigliotti R, Chapman BP, Joseph J, Smiley A, Hunter M, Soucie N, Gross K, Babu KM, Weisberg SN. Creating Opioid Response Specialists: A Harm Reduction Initiative. Prehosp Emerg Care. 2025; 29(4):540-545.
-
Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 07; 119(7):1313-1321.
-
Westafer LM, Beck SA, Simon C, Potee B, Soares WE, Schoenfeld EM. Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience. Ann Emerg Med. 2024 04; 83(4):340-350.
-
Hoover DB, Korthuis PT, Waddell EN, Foot C, Conway C, Crane HM, Friedmann PD, Go VF, Nance RM, Pho MT, Satcher MF, Sibley A, Westergaard RP, Young AM, Cook R. Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities. JAMA Netw Open. 2023 11 01; 6(11):e2342222.
-
Davis A, Stringer KL, Drainoni ML, Oser CB, Knudsen HK, Aldrich A, Surratt HL, Walker DM, Gilbert L, Downey DL, Gardner SD, Tan S, Lines LM, Vandergrift N, Mack N, Holloway J, Lunze K, McAlearney AS, Huerta TR, Goddard-Eckrich DA, El-Bassel N. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study. Int J Drug Policy. 2023 12; 122:104241.
-
Pepin MD, Joseph JK, Chapman BP, McAuliffe C, O'Donnell LK, Marano RL, Carreiro SP, Garcia EJ, Silk H, Babu KM. A mobile addiction service for community-based overdose prevention. Front Public Health. 2023; 11:1154813.